| Prominence Energy Limited (PRM) ORDINARY FULLY PAID |
Energy |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 1:28PM |
$0.004 |
$0.004 |
fallen by
0%
|
|
PRM - Price-sensitive ASX Announcement
Full Release
Key Points
- Prominence Energy completed the acquisition of the Gawler Natural Hydrogen Project.
- Final regulatory approval was received for the Change of Control of PEL 803.
- Prominence secured a strategic land position across the Gawler Craton.
- Significant technical de-risking was completed across PEL 803.
- Planning is advanced for an integrated geochemical survey in PEL 803.
- Prominence's cash flow from operating activities was negative.
- Net cash from financing activities included proceeds from equity securities.
- Prominence joined the Australian Clean Hydrogen and CCS Delegation to H2MEET Korea 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayfield Childcare Limited (MFD) ORDINARY FULLY PAID |
Consumer Discretionary |
$40 |
Launch of Mayfield 360 Allied Health Services
|
29 Jan 2026 1:26PM |
$0.495 |
$0.525 |
risen by
6.06%
|
|
MFD - Price-sensitive ASX Announcement
Full Release
Key Points
- Launch of Mayfield 360 Allied Health Services announced.
- Expansion includes Occupational Therapy, Speech Pathology, and Developmental Services.
- Focus on enhancing child outcomes and supporting families within the ECEC network.
- Strategy to diversify earnings and promote sustainable growth.
- Strong initial demand and enrolments noted.
- Aligns with opportunities in the Allied Health and NDIS sectors.
- Supported by demographic trends and government funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$6 |
Dec25 Quarterly Activities Report
|
29 Jan 2026 1:25PM |
$0.024 |
$0.025 |
risen by
4.17%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of $750,000 placement and $107,730 entitlement offer for operational costs.
- Funding agreement extension of $12.6 million with Linlithgow Family Office for SRX-25 development.
- Manufacturing completion for IRX-211 and IRX-616a trial drugs.
- IRX-211 Phase 2 trial preparation, including site agreements and initiation visits.
- IRX-616a Phase 1 trial agreements and manufacturing finalization.
- Significant progress on SRX-25 Phase 1 trial protocol and investigator brochure.
- Dec25 clinical development costs totaled $485k with funding support from Clendon/LFO.
- Rebranding to Nexalis Therapeutics Limited pending shareholder approval.
- Aim to secure FDA NDA approvals using cost-effective regulatory pathways.
- Strategic focus on addressing unmet medical needs in pain and mental health.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Voltaic Strategic Resources Ltd (VSR) ORDINARY FULLY PAID |
Materials |
$30 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 1:18PM |
$0.045 |
$0.052 |
risen by
15.56%
|
|
VSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Voltaic continued significant exploration efforts in Western Australia.
- Neo prospect shows promising results for Gallium and Rare Earth Elements.
- Net cash outflow of $154,000 from operating activities.
- Investing cash outflow totaled $556,000.
- Cash and cash equivalents stood at $1.845 million at quarter-end.
- Strategic focus on gallium's role in critical supply chains.
- No major financing activities occurred in the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$6 |
Dec25 Appendix 4C Cash Flow Report
|
29 Jan 2026 1:16PM |
$0.024 |
$0.025 |
risen by
4.17%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash outflow of $628,000 from operating activities
- Government grants and tax incentives received
- No significant cash flows from investing activities
- Net cash inflow of $894,000 from financing activities
- Funding facility of $38.5 million for clinical trials
- Cash and cash equivalents of $436,000 at quarter's end
- Unused finance facilities of $50,787,000 available
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Red Hill Minerals Limited (RHI) ORDINARY FULLY PAID |
Materials |
$300 |
Quarterly Activities, App 5B Cash Flow Report & Tenement
|
29 Jan 2026 1:15PM |
$4.950 |
$4.680 |
fallen by
5.45%
|
|
RHI - Price-sensitive ASX Announcement
Full Release
Key Points
- Royalty revenue for the quarter was $7.8 million.
- Cash balance at quarter-end was $61.3 million.
- Dividend paid was $4.2 million with exploration expenditure of $2.7 million.
- Significant diamond drilling program completed at Broken Hill Project.
- Successful results from the Anabama Project diamond drill program.
- Net cash from operating activities was $5.4 million.
- Focus on exploration and evaluation investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$62 |
Neurizon secures $6million R&D Tax Incentive Rebate
|
29 Jan 2026 1:12PM |
$0.084 |
$0.090 |
risen by
7.14%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon secured a $6 million cash rebate under Australia's R&D Tax Incentive program for FY2025.
- The rebate reflects a 48.5% return on eligible R&D activities, including foreign expenditures.
- Funds will support the HEALEY ALS Platform Trial and expand the NUZ-001 pipeline.
- The rebate is part of a funding strategy announced in December 2025.
- Neurizon aims to advance treatments for ALS and broader neurodegenerative diseases.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$47 |
Application for quotation of securities - AR9
|
29 Jan 2026 1:08PM |
$0.105 |
$0.098 |
fallen by
6.67%
|
|
| Green Technology Metals Limited (GT1) ORDINARY FULLY PAID |
Materials |
$21 |
Ceasing to be a substantial holder
|
29 Jan 2026 1:05PM |
$0.042 |
$0.033 |
fallen by
21.43%
|
|
| Astral Resources NL (AAR) ORDINARY FULLY PAID |
Materials |
$441 |
Change of Director's Interest Notice (x3)
|
29 Jan 2026 1:04PM |
$0.270 |
$0.245 |
fallen by
9.26%
|
|
| Green Technology Metals Limited (GT1) ORDINARY FULLY PAID |
Materials |
$21 |
Ceasing to be a substantial holder
|
29 Jan 2026 1:03PM |
$0.042 |
$0.033 |
fallen by
21.43%
|
|
| Pursuit Minerals Limited (PUR) ORDINARY FULLY PAID |
Materials |
$23 |
Suspension from Quotation
|
29 Jan 2026 12:58PM |
$0.120 |
$0.120 |
fallen by
0%
|
|
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
Investor Presentation
|
29 Jan 2026 12:56PM |
$0.083 |
$0.089 |
risen by
7.23%
|
|
| Australian Critical Minerals Limited (ACM) ORDINARY FULLY PAID |
Materials |
$7 |
Flint Drill Ready Gold-Silver Project Update
|
29 Jan 2026 12:54PM |
$0.083 |
$0.089 |
risen by
7.23%
|
|
ACM - Price-sensitive ASX Announcement
Full Release
Key Points
- Comprehensive review of NSAMT geophysics, geochemistry, mapping, and IP data completed.
- Large gold and silver geochemical anomaly defined, indicative of a High Sulphidation Epithermal deposit.
- System indicated to have a strike length of 4km.
- Located 80km east of Trujillo, Peru, within a prolific epithermal belt.
- Initial program of 4 priority diamond drillholes for 1850m to commence this quarter.
- NSAMT survey identified resistive targets over approximately 4km.
- Surface access agreements signed and Environmental Permit approved.
- Project sits within a highly endowed epithermal gold-silver province.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$48 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2026 12:53PM |
$0.070 |
$0.061 |
fallen by
12.86%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- ASF Group Limited ended the quarter with a cash balance of $1.910 million.
- Net cash used in operating activities was $484,000.
- No financing facilities were drawn upon during the quarter.
- ASF holds significant investments in ActivEX Limited and Key Petroleum Limited.
- ASF's subsidiary, ASF Coking Coal Pty Ltd, holds coal tenements in Queensland.
- ASF Properties Pty Ltd provides property services in New South Wales and Queensland.
- ASF Capital is registered with AUSTRAC as a Digital Currency Exchange service provider.
- The company expects available funding for approximately 3.94 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMC Gold Corporation (EM3) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$36 |
Quarterly Activities Report & Cashflow
|
29 Jan 2026 12:50PM |
$0.088 |
$0.089 |
risen by
1.14%
|
|
EM3 - Price-sensitive ASX Announcement
Full Release
Key Points
- EMC Gold changed its name from Black Dragon Gold Corporation.
- The company withdrew the PIER application for the Salave Gold Project.
- Successful equity placement to Spanish and Asturian investors completed.
- CAD$4,836,000 cash position at the quarter's end.
- No exploration activity at Ivan Well in Australia.
- Salave is one of the largest undeveloped gold projects in Europe.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Activex Limited (AIV) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 12:49PM |
$0.022 |
$0.022 |
fallen by
0%
|
|
AIV - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed $800,000 placement to True Creation Limited and $100,000 placement to Business Victor Investments Limited.
- Gilberton Gold Project drilling program completed, aimed at increasing the Mineral Resource Estimate.
- Westgrove REE Project nearing execution of Native Title Exploration Agreements.
- Cash position at $98,000 as of 31 December 2025.
- Amendment of repayment terms for $5 million unsecured loan facility with Star Diamond Developments Limited.
- Directors' fees totaled $59,000 for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tourism Holdings Rentals Limited (THL) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$478 |
Change in substantial holding
|
29 Jan 2026 12:44PM |
$2.210 |
$2.160 |
fallen by
2.26%
|
|
| Avenira Limited (AEV) ORDINARY FULLY PAID |
Materials |
$34 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 12:40PM |
$0.007 |
$0.008 |
risen by
14.29%
|
|
AEV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly report for the period ending 31 December 2025.
- Focus on Wonarah Phosphate and Jundee South Projects.
- Strengthened operational capacity with new hires.
- Ongoing government engagement and infrastructure planning.
- Cash inflows from financing activities and operational outflows.
- Cash balance of AUD 2,268,000 at the end of the quarter.
- Optimistic about future capital raising.
- Compliance with financial and operational standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kalgoorlie Gold Mining Limited (KAL) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 12:38PM |
$0.050 |
$0.045 |
fallen by
10%
|
|
KAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful RC drill program at Lighthorse extends gold mineralisation over 1,100 meters.
- Diamond drilling completed at Kirgella Gift and Providence with assays awaited.
- Balance sheet strong with $4.0 million cash and no debt as of 31 December 2025.
- Net cash outflow from operating activities was $265,000 for the quarter.
- Substantial investment in exploration, totalling $1,525,000 over six months.
- Upcoming drill programs planned to further explore and define gold targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infini Resources Limited (I88) ORDINARY FULLY PAID |
Materials |
$29 |
Application for quotation of securities - I88
|
29 Jan 2026 12:38PM |
$0.270 |
$0.275 |
risen by
1.85%
|
|
| Infini Resources Limited (I88) ORDINARY FULLY PAID |
Materials |
$29 |
30% Expansion of Portland Creek Footprint Complete
|
29 Jan 2026 12:38PM |
$0.270 |
$0.275 |
risen by
1.85%
|
|
| Moonlight Resources Ltd (ML8) ORDINARY FULLY PAID |
Materials |
$11 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 12:33PM |
$0.195 |
$0.190 |
fallen by
2.56%
|
|
ML8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Successfully completed IPO and commenced trading on ASX on 11 December 2025.
- Raised A$10 million to fund exploration activities.
- Commenced confirmatory and infill drilling at the Leo Grande Prospect, Clermont Project.
- Intersected gold mineralization in fourteen RC drill holes.
- Strong cash balance of A$9.03 million at quarter end.
- No mining production or development activities during the quarter.
- Fifteen Exploration Licences held, two under application.
- Focused on gold and REE-uranium projects in Queensland, Northern Territory, Western Australia, and New South Wales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$90 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2026 12:23PM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| McLaren Minerals Limited (MML) ORDINARY FULLY PAID |
Materials |
$9 |
Ceasing to be a substantial holder
|
29 Jan 2026 12:23PM |
$0.025 |
$0.023 |
fallen by
8%
|
|